Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. | Lancet Neurol | 2020 | 3.93 |
2 | Levels of nitric oxide metabolites in cerebrospinal fluid correlate with cognitive impairment in early stage multiple sclerosis. | J Neurol Neurosurg Psychiatry | 2017 | 0.75 |